Alzheimer's LINX makes it easier to see the route of pathogenesis leading to cognitive decline, and devise strategies to stop it. By addressing Blood-Brain Barrier (BBB) breakdown, identifying and removing triggers and enhancing neuronal regeneration, one might be able to win the war on cognitive decline. Clinical Use: To identify patients at greater risk for developing Alzheimer's disease or other neurological disorders. To identify reactivity to triggers of Alzheimer's disease or other neurological disorder. To identify the early stage of neurodegenerative processes. To monitor the effectiveness of lifestyle modifications for Alzheimer's disease. Recommended For Patients Who: Are interested in preventing the development of Alzheimer's disease or other neurological disorder. Are exhibiting early signs of Alzheimer's disease or other neurological disorder. Have been diagnosed with Alzheimer's disease. Have a history of gastrointestinal disorders and/or diabetes. Played high-impact sports. Are immunoreactive against specific pathogens, chemicals and foods. Antigens Tested: Brain Proteins Tau Protein Amyloid-Beta Peptide Rabaptin-5 + Presenilin Alpha-Synuclein Growth Factors Beta Nerve Growth Factor Brain Derived Neurotrophic Factor Neurotrophins Somatotropin IgG Enteric Nerve, Enzymes and Neurological Peptides Transglutaminases Enteric Nerve + Vasoactive Intestinal Peptide Pathogens Oral Pathogens Enterococcus faecalis Escherichia coli CDT + Salmonella CDT Campylobacter jejuni CDT Herpes Type-1 Chemicals Aluminums Dinitrophenyl Ethyl + Methyl Mercury Phthalates IgG Foods Cross-Reactive to Amyloid-Beta Egg Yolk, raw + cooked Lentil Lectin + Pea Lectin Tuna, canned IgG Hazelnut Vicilin + Cashew Vicilin Scallops + Squid Caseins Alpha-Gliadin + Gliadin Toxic Peptide Non-Gluten Wheat Proteins Blood-Brain Barrier and Neurofilaments Blood-Brain Barrier Protein + Claudin-5 Aquaporins Neurofilaments Proteins